{"id":510,"date":"2011-04-18T14:41:09","date_gmt":"2011-04-18T18:41:09","guid":{"rendered":"http:\/\/www.marshall.edu\/ori\/?page_id=510"},"modified":"2019-01-16T09:58:37","modified_gmt":"2019-01-16T14:58:37","slug":"irb1-initial-protocol-application-instructions","status":"publish","type":"page","link":"https:\/\/www.marshall.edu\/ori\/office-of-research-integrity\/human-subject-research\/institutional-review-boards\/institutional-review-board-1-medical\/irb-1-initial-application-package\/irb1-initial-protocol-application-instructions\/","title":{"rendered":"IRB#1 Initial Protocol Application Instructions"},"content":{"rendered":"<p><strong>PART I, page 1<\/strong><\/p>\n<p>Please be advised that <strong>STUDENTS<\/strong>\u00a0and <strong>RESIDENTS<\/strong> (including <strong>FELLOWS<\/strong>) are not permitted to serve as a Principal Investigator.\u00a0 They may be listed as Co-Investigators only and must complete Attachment C on pages 13 &amp;14 of the application (or Attachment C if there is more than one).<\/p>\n<p><strong>Personal Information:\u00a0 <\/strong>Complete all requested information, if this is a student-generated research protocol insert the student&#8217;s name under that question. \u00a0As part of the requirement for submission, you must include: A) a copy of your CV, B) current applicable license, and C) Board Certification information for the purpose of verification of credentials if applicable.<\/p>\n<p>If you will be conducting this research protocol at the Huntington VAMC, you must also attach the proper VA forms.\u00a0 VA forms are located on the VA page of the Office of Research Integrity (ORI) website.<\/p>\n<p><strong>PART I, page 2,3<\/strong><\/p>\n<p><strong>Research Experience<\/strong><strong>:\u00a0 <\/strong>Please answer all questions concerning your research experience.<\/p>\n<p><strong>Conflict of Interest:\u00a0 <\/strong>All Conflict of Interest questions must be answered.\u00a0 If you answer &#8220;Yes&#8221; to any question you must complete the Significant Financial Disclosure Form (SFID) which is located in the Forms and Templates library on IRBNet.\u00a0 Definitions of what constitutes a Conflict of Interest can be found in the Standard Operating Procedures (SOP) Manual (also located in the IRBNet library).<\/p>\n<p><strong>Research Staff:\u00a0 <\/strong>Please include the names and position of all co-investigators and research staff personnel who will be directly involved with this study.\u00a0 All personnel listed will be required to complete the required training and must also acknowledge any conflicts-of-interest.\u00a0 All listed co-investigators and research staff are required to submit a copy of the Attachment C form located in the IRBNet library.\u00a0 The following items must be included for each research staff member when submitting this application to the MU IRB:\u00a0 (1) an Attachment C form, (2) a copy of their CV\/resume, current license and Board Certification (if applicable), and (3) copies of current CITI certificates.<\/p>\n<p>List the external sites where the research will be conducted (e.g. schools, business, and health care facilities).\u00a0 <strong>Note:<\/strong> You must obtain written permission from the external sites prior to study approval.<\/p>\n<p><strong>PART II, page 4, 5, 6, 7<\/strong><\/p>\n<p><strong>Selection of Facilities:<\/strong>\u00a0 Please select all facilities where this research will be conducted. (If you select the Huntington VAMC, there will be additional documents to complete.\u00a0 This information will follow as it pertains to different areas of the protocol submission process.)<\/p>\n<p><strong>Section A<\/strong><\/p>\n<p><strong>Protocol Description:\u00a0\u00a0 <\/strong>Answer these questions concerning whether or not the study involves minimal risk.<\/p>\n<p><strong>Section B<\/strong><\/p>\n<p><strong>Sponsored Studies:<\/strong>\u00a0 If the study is sponsored then complete this section.\u00a0 If it is not applicable then click N\/A.\u00a0 Please provide sponsor contact information for billing purposes.<\/p>\n<p><strong>Test Article:<\/strong> If the study involves investigational drugs or devices you must complete this section and attach a description of the procedures that will be followed so that only authorized individuals will be able to access the investigational drugs or devices and that they will only be used for individuals who are participants in this research protocol.\u00a0 Also provide the IND# and IDE# if applicable.<\/p>\n<p><strong>Section C<\/strong><\/p>\n<p><strong>Study Subjects and Procedures:<\/strong> Enter the minimum and maximum number of anticipated subjects for the study.\u00a0 Also insert the minimum and maximum number of participants that you would allow.\u00a0 Include the minimum and maximum ages of participants.\u00a0 If there is no maximum age then just enter N\/A.\u00a0 Be sure to answer each question in this section.\u00a0 If your study only involves records review then you can skip this section and proceed to Section D.<\/p>\n<p><strong>Section D<\/strong><\/p>\n<p><strong>Recruitment: <\/strong>This section must be completed.\u00a0 State where your study subjects or records will be drawn.\u00a0 If any of the questions are not applicable to your study then put a checkmark in the N\/A box.\u00a0 All advertisements must be submitted and approved.\u00a0 Keep in mind that finder\u2019s fees (as described on the application) are not permitted.<\/p>\n<p><strong>Section E<\/strong><\/p>\n<p><strong>Informed Consent:<\/strong>\u00a0 If your study protocol does not require a Consent Form, please click N\/A and proceed to Section F.\u00a0 If your study protocol will be using a consent, please refer to the consent templates in the IRBNet library.\u00a0 The consent must either contain all elements of HIPAA or a HIPAA consent must also be submitted separately.\u00a0 If the consent form will be translated into a foreign language then you must provide both the English and Foreign language copies of the consent.<\/p>\n<p>If the consent will be used at the Huntington VAMC, the consent must include 10-1086 forms.\u00a0 If you desire assistance on the proper format for a VA consent, please refer to the VA consent templates.\u00a0 The 10-1086 form and the consent template can be located on the ORI website. If the consent form will be translated into a foreign language then you must provide both the English and Foreign copies of the consent.<\/p>\n<p><strong>Assent and Parental Permission Forms: <\/strong>\u00a0If your study protocol will be using children under the age of 18 years old, you must submit an assent and a Parental Permission Form. Please refer to the Informed Consent chapter of the SOP for additional information.\u00a0 Templates are available in the IRBNet library.<\/p>\n<p><strong>Section F<\/strong><\/p>\n<p><strong>Confidentiality:<\/strong>\u00a0 Please provide the information related to confidentiality.\u00a0 Remember that this information pertains to how you will protect the data of the participants.<\/p>\n<p><strong>Section G<\/strong><\/p>\n<p><strong>Privacy:<\/strong> \u00a0You must describe the provisions to protect the privacy interests of participants.\u00a0 Remember that this information pertains to how you will protect the privacy of the subject (i.e. interview\/survey participant in private).<\/p>\n<p><strong>Section H<\/strong><\/p>\n<p><strong>Monetary Reimbursement:<\/strong>\u00a0 Each question in this section must be answered.\u00a0 If there are no subject charges the checkmark the N\/A box and skip to the next section.<\/p>\n<p><strong>Abstract:<\/strong>\u00a0 Please provide a brief abstract of your proposed research in 1-2 pages maximum.\u00a0 It must be written in lay terms since an IRB member (i.e. Community Representative) may not have a background in your particular scientific field. The outline format for the abstract should be written as follows:\u00a0 (1) The Purpose of the Research (Objectives), (2) The Scientific or Scholarly Rationale (Research Plan), (3) Procedures to be Performed (Methods), (4) A Description of What Procedures Were Being Performed Already for Diagnostic or Treatment Purposes (if any), (5) Risks and Potential Benefits of the Research (include safeguards provided), and (6) Complete Inclusion\/Exclusion Criteria can be submitted separately.\u00a0\u00a0\u00a0\u00a0 <strong><br \/>\n<\/strong><\/p>\n<p><strong>PART III, page 8<\/strong><\/p>\n<ol>\n<li>As a requirement for the submission of this application, all personnel directly involved with this research protocol <strong>MUST<\/strong> complete the CITI Educational training <strong>BEFORE<\/strong> submitting this protocol to the MU IRB for review. CITI registrations are available on the Education page of the ORI website. For questions about the CITI course you can contact Dr. Bruce Day. He is available for questions from 8 a.m. to 4:30 p.m., 5 days a week and can be reached at 304-696-4303 or <a href=\"mailto:day50@marshall.edu\">day50@marshall.edu<\/a>.<\/li>\n<li>The MU Standard Operating Procedures (SOP) is available in the IRBNet library. You are required to familiarize yourself with our procedures.<\/li>\n<\/ol>\n<p><strong>PART IV, page 8<\/strong><\/p>\n<p><strong>Type of Review Requested<\/strong>:\u00a0 Please review Attachments A and B, which list the criteria for Exempt and Expedited review.\u00a0 Please indicate which type of review you believe your protocol should receive.\u00a0 If this protocol does not meet the criteria for Exempt or Expedited review, the protocol must receive a full board review.\u00a0 The IRB Chairperson or their designee will make this Exempt or Expedited determination.<\/p>\n<ul>\n<li><strong>Exempt:<\/strong> If you request Exempt then choose the applicable Exempt category on page 10.<\/li>\n<li><strong>Expedited:<\/strong> If you request Expedited you <strong>must<\/strong> complete and include the Expedited Protocol Assessment Form located in the IRBNet library and choose the applicable Expedited category on page 12.<\/li>\n<li><strong>Convened:<\/strong> You must complete and include the Initial Protocol Assessment Form.<\/li>\n<li><strong>CIRB:<\/strong> If you are requesting a review from the CIRB then you must complete and include the CIRB application.<\/li>\n<\/ul>\n<p><strong>Fees<\/strong>:\u00a0 Please read this section on applicable fees and waivers.<\/p>\n<p><strong>PART V, page 9<\/strong><\/p>\n<p><strong>Certification and Assurance<\/strong>:\u00a0 By electronically signing the study on IRBNet you giving your assurance of the times in this section.<\/p>\n<p><strong>Submission Information<\/strong>: There is also a submission list in the IRBNet library that indicates all the documents needed for a submission.\u00a0 If your study required full board review then the deadline for submission is 30 days prior to the meeting.\u00a0 The IRB#1 (Medical) board meets the second Wednesday of each month.\u00a0 Exempt and Expedited studies can be submitted at any time since they only require Chair or Designee review and approval.<\/p>\n<p>To comply with the ORI\/IRB deadlines, it is very important that the principal investigator take the responsibility to review the exempt and expedited criteria checklists thoroughly to ensure that the correct type of review is selected and the correct documentation is submitted for review.\u00a0 The IRB Chairperson or his\/her designee will make the Exempt or Expedited determination.\u00a0 In the event that a PI\u2019s request for exempt or expedited review is not accepted by the IRB Chairperson or his\/her designee, the PI will be notified immediately to complete, and attach on IRBNet, the Initial Assessment Form.<\/p>\n<p><strong>MU IRB Coordinator<\/strong>:\u00a0 The MU IRB Coordinator is Mrs. Trula Stanley.\u00a0 She is available for questions from 8 a.m. to 4:30 p.m., 5 days a week.\u00a0 Mrs. Stanley can be reached at 304-696-7320 or <a href=\"mailto:stanley@marshall.edu\">stanley@marshall.edu<\/a>.<\/p>\n<p><strong>ATTACHMENT A<\/strong><\/p>\n<p><strong>Exempt Status<\/strong>:\u00a0 This checklist delineates all of the categories that qualify a protocol for exempt review.\u00a0 A study must fall into one of these categories to qualify as exempt.\u00a0 If a protocol receives exempt status, it will be reported as informational at the next IRB meeting.<\/p>\n<p><strong>ATTACHMENT B<\/strong><\/p>\n<p><strong>Expedited Review Criteria<\/strong>:\u00a0 This checklist describes all of the categories that qualify a protocol for expedited review.\u00a0 In order for a protocol to qualify for this type of review, it must pose no more than minimal risk and fall into one of the 7 categories.\u00a0 If a protocol receives expedited approval it will be reported as informational at the next IRB meeting.<\/p>\n<p><strong>ATTACHMENT C<\/strong><\/p>\n<p><strong>Co-Investigators\/Research Staff Information and Certification<\/strong>:\u00a0 This is the verification form that is used by the co-investigators and research staff that assures that they have completed all required training, all conflicts-of-interest have been revealed, and that they will protect the rights and welfare of each subject to the best of their ability.\u00a0 This form must be completed by all individuals that are listed as research staff for this protocol.\u00a0 If you need addition Attachment Cs then you can find the form in the IRBNet library.\u00a0 Note: This form does not need to be completed by the principal investigator.<strong>\u00a0<\/strong><\/p>\n<p><strong>IMPORTANT MISCELLANEOUS IRB INFORMATION<\/strong><\/p>\n<p><strong>Continuing Review<\/strong>:\u00a0 The Board will determine the frequency for continuing review for each protocol that is approved.\u00a0 It is the principal investigator\u2019s responsibility to ensure that their protocol does NOT exceed the expiration date for their protocol.\u00a0 If this occurs, the study will be closed automatically and the investigator will have to re-submit the protocol as a new submission.\u00a0 This process will take place for every continuing review for the duration of the protocol.\u00a0 <strong>If at any time the protocol is CLOSED, please submit a closure request package immediately through IRBNet and the protocol will be closed.<\/strong>\u00a0 For more information about how to submit a Continuing Review, please refer to the IRBNet User Manual.<\/p>\n<p><strong>Ensuring Prompt Reporting of Unanticipated Problems Involving Risks to Participants or Others:\u00a0 <\/strong>All unanticipated problems involving risks to participants or others must be submitted to the IRB as soon as possible.\u00a0 To submit these problems, the principal investigator must complete an Adverse Event or Other Problem Report Form located in the IRBNet library.\u00a0 You can also read more information concerning this subject in the SOP.\u00a0 The form must be completed and electronically signed by the principal investigator.<\/p>\n<p><strong>Random Audits:<\/strong>\u00a0 ORI is tasked with conducting random audits of ACTIVE studies.\u00a0 If your study is selected for a random audit then the IRB Coordinator will contact you and set up and time and place for the audit.\u00a0 For cause audits are also conducted if necessary.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>PART I, page 1 Please be advised that STUDENTS\u00a0and RESIDENTS (including FELLOWS) are not permitted to serve as a Principal Investigator.\u00a0 They may be listed as Co-Investigators only and must complete Attachment C on pages 13 &amp;14 of the application (or Attachment C if there is more than one). Personal Information:\u00a0 Complete all requested information,<\/p>\n","protected":false},"author":15,"featured_media":0,"parent":534,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-sidebar-right.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-510","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.marshall.edu\/ori\/wp-json\/wp\/v2\/pages\/510","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marshall.edu\/ori\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.marshall.edu\/ori\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.marshall.edu\/ori\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marshall.edu\/ori\/wp-json\/wp\/v2\/comments?post=510"}],"version-history":[{"count":0,"href":"https:\/\/www.marshall.edu\/ori\/wp-json\/wp\/v2\/pages\/510\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.marshall.edu\/ori\/wp-json\/wp\/v2\/pages\/534"}],"wp:attachment":[{"href":"https:\/\/www.marshall.edu\/ori\/wp-json\/wp\/v2\/media?parent=510"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}